Mrs. Jennifer Ragan Vanleeuwen, APRN/CNS Clinical Nurse Specialist - Oncology Medicare: Accepting Medicare Assignments Practice Location: 9301 W 74th St, Suite 100, Shawnee Mission, KS 66204 Phone: 913-632-9100 |
Kathleen Ann Henderson, RN Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2831 Fax: 913-632-2898 |
Susan R. Schedler, A.P.R.N Clinical Nurse Specialist - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2368 |
News Archive
Shield Healthcare, a leading provider of medical supplies for care at home, is pleased to announce its 9th annual story contest on "What Makes Caregiving Rewarding?" designed to recognize and hear the voice of caregivers and home healthcare professionals, featuring celebrity contest judge, Sandra Mitchell of KCAL 9/CBS 2 News. Shield Healthcare understands that caregiving is a demanding job. A significant number of our customers are family caregivers at home, tending to a loved one with a chronic medical condition.
Patients who received an implantable heart defibrillator in everyday practice had survival benefits on par with those who received the same devices in carefully controlled clinical trials, according to a new study that highlights the value of defibrillators in typical medical settings.
Biosense Webster announces that this week it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO(R) 3 System-guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) Catheter versus fluoroscopy-guided radiofrequency ablation using the Pulmonary Vein Ablation Catheter(R) (PVAC(R), Ablation Frontiers, Medtronic) in patients with paroxysmal atrial fibrillation.
Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) Pharmaceutical Companies, today will present results of the final analysis of PILLAR, a phase 2b study of the investigational hepatitis C virus (HCV) NS3/4A protease inhibitor TMC435 in treatment-naïve patients with chronic genotype 1 HCV, as part of a late-breaker oral presentation at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, CA, USA.
Weightlifting may play a key role in the prevention of the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine. Combined with the team's previous findings that the exercise limits a worsening of symptoms among women who already have lymphedema, the new data cements the reversal of long-running advice that breast cancer survivors should avoid lifting anything heavier than five pounds after they finish treatment.
› Verified 8 days ago